Literature DB >> 11881727

Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases.

Y Yatabe1, R Suzuki, Y Matsuno, K Tobinai, R Ichinohazama, J Tamaru, Y Mizoguchi, Y Hashimoto, M Yamaguchi, M Kojima, N Uike, M Okamoto, K Isoda, K Ichimura, Y Morishima, M Seto, T Suchi, S Nakamura.   

Abstract

Immunostaining for cyclin D1 is essential for reliable diagnosis of mantle cell lymphoma (MCL). However, a small number of cyclin D1-positive lymphomas other than MCL have been encountered. Our goal was to investigate the morphological spectrum of MCL as a disease entity, based on cyclin D1 overexpression. We reviewed 181 biopsy specimens obtained from 168 cases of cyclin D1-positive MCL. Typical findings were the presence of nodular (53.9% of cases) or diffuse (46.1%) histological patterns, containing mantle zone patterns (16.8%), naked germinal centers (33.5%) and perivascular hyaline deposition (83.2%). Unusual findings of residual germinal centers with a mantle cuff (four cases) and follicular colonization (two cases) were seen. High magnification showed a monotonous proliferation of tumor cells with cytological diversity including small (3.0%), intermediate (43.1%), medium (34.1%), medium-large (13.2%) and large (6.6%) cells. Pleomorphic and blastic/blastoid variants were encountered in 9.6 and 7.2% of cases, respectively. Three cases had foci of cells of considerable size, with a moderately abundant pale cytoplasm resembling marginal zone B cells. Two cases showed an admixture of cells which appeared transformed and mimicked the histology of chronic lymphocytic leukemia/small lymphocytic leukemia. In one, neoplastic mantle zones were surrounded by sheets of mature plasma cells, resembling the plasma cell type of Castleman's disease. An admixture of areas characteristic of MCL and of other larger cells, indicating histological progression or a composite lymphoma, were observed in seven cases. In high-grade lesions of five cases, nuclear staining of cyclin D1 was rarely detected. In our experience, cyclin D1 expression was also found in nine lymphomas other than MCL (five plasma cell myelomas, three Hodgkin's disease and one anaplastic large cell lymphoma). The application of cyclin D1 staining prompted us to recognize the broad morphological spectrum of MCL. MCL can be diagnosed with the application of cyclin D1 immunostaining, if careful attention is given to architectural and cytological features.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11881727     DOI: 10.1046/j.1440-1827.2001.01277.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  11 in total

1.  MALT type lymphoma demonstrating prominent plasma cell differentiation resembling fibrous variant of Hashimoto's thyroiditis: a three case report.

Authors:  Masaru Kojima; Naoya Nakamura; Kazuhiko Shimizu; Atsuki Segawa; Sadayuki Kaba; Nobuhide Masawa
Journal:  Pathol Oncol Res       Date:  2008-10-17       Impact factor: 3.201

2.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Proteomic analysis of mantle-cell lymphoma by protein microarray.

Authors:  Irene M Ghobrial; Daniel J McCormick; Scott H Kaufmann; Alexey A Leontovich; David A Loegering; Nga T Dai; Kelly L Krajnik; Mary J Stenson; Mona F Melhem; Anne J Novak; Stephen M Ansell; Thomas E Witzig
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

4.  An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.

Authors:  Mauricio Zapata; Steven D Budnick; Rodolfo Bordoni; Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2010-03-20

5.  Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.

Authors:  Dong Chen; Mark E Law; Jason D Theis; Jeffrey D Gamez; Lynn B Caron; Julie A Vrana; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

6.  Cyclin D1 expression in peripheral T-cell lymphomas.

Authors:  Joo Y Song; Liping Song; Alex F Herrera; Girish Venkataraman; Joyce L Murata-Collins; Victoria H Bedell; Yuan Yuan Chen; Young S Kim; Reda Tadros; Bharat N Nathwani; Dennis D Weisenburger; Andrew L Feldman
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

7.  Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.

Authors:  Robert S Boyd; Rebekah Jukes-Jones; Renata Walewska; David Brown; Martin J S Dyer; Kelvin Cain
Journal:  Mol Cell Proteomics       Date:  2009-04-02       Impact factor: 5.911

8.  MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Authors:  Fatima Hamadeh; Stephen P MacNamara; Nadine S Aguilera; Steven H Swerdlow; James R Cook
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

9.  Fine needle aspiration cytology in the diagnosis of uncommon types of lymphoma.

Authors:  F Mayall; A Darlington; B Harrison
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

Review 10.  Mantle cell lymphoma: therapeutic strategies are different from CLL.

Authors:  Wolfgang Hiddemann; Martin Dreyling
Journal:  Curr Treat Options Oncol       Date:  2003-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.